About Matthew Stahl
Form D filings for Steel Therapeutics from 2021 to 2024 list Matthew Stahl as executive officer, director and promoter.
Matthew Stahl first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Matthew Stahl in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Stahl works with at each company, as listed on that company's latest Form D.
Steel Therapeutics, Inc. · Form D, Dec 5, 2024
AP
Allen Phillips
Director
SC
Sunny Chapel
Director
BC
Benjamin Clark
Executive officer and promoter
DS
Dennis Sparks
Director
RS
Robbie Schwenker
Director